{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T16:22:10Z","timestamp":1762878130154,"version":"3.45.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ophthal Inflamm Infect"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Cannabis use has increased substantially worldwide, yet its association with inflammatory eye diseases remains poorly understood. This study evaluated whether cannabis users have higher risk of developing uveitis and related inflammatory ocular conditions compared to non-users.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective cohort study using the TriNetX Global Collaborative Network database. Adult patients with documented cannabis-related disorders were propensity score-matched 1:1 to patients with no cannabis use, excluding individuals with prior diagnoses that could independently cause uveitis. The primary outcome was the incidence of any uveitis. Secondary outcomes included specific uveitis subtypes, retinal vasculitis, and choroidal degeneration, assessed starting 1 year after cohort entry. Kaplan-Meier survival analysis and Cox proportional hazards models compared outcomes between groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      After propensity matching, 1,156,655 cannabis users were compared with 1,156,655 matched non-users. Cannabis use was associated with significantly increased risk of any uveitis (hazard ratio [HR] 1.8, 95% confidence interval [CI] 1.65\u20131.95,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.0001). Specific uveitic conditions showed higher relative risks: panuveitis demonstrated the strongest association (HR 3.64, 95% CI 2.24\u20135.91,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.0001), followed by choroidal degeneration (HR 3.29, 95% CI 1.74\u20136.23,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.0001) and retinal vasculitis (HR 3.27, 95% CI 1.81\u20135.89,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.0001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Cannabis use was associated with statistically and clinically significant increased risk of ocular inflammatory diseases, particularly those affecting the posterior eye segment. These findings have important implications for ophthalmologic screening and patient counseling as cannabis use becomes more widespread.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12348-025-00544-z","type":"journal-article","created":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T15:33:38Z","timestamp":1762875218000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association between cannabis use and ocular inflammatory disease: a large-scale cohort study"],"prefix":"10.1186","volume":"15","author":[{"given":"Natan","family":"Lishinsky","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ortal","family":"Buhbut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoham","family":"Kubovsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nir","family":"Erdinest","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Radgonde","family":"Amer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zvi","family":"Gur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,11]]},"reference":[{"key":"544_CR1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2025.4358","author":"P Maghsoudlou","year":"2025","unstructured":"Maghsoudlou P, Epps SJ, Guly CM, Dick AD (2025) Uveitis in adults: a review. JAMA (in press). https:\/\/doi.org\/10.1001\/jama.2025.4358","journal-title":"JAMA (in press)"},{"issue":"25","key":"544_CR2","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1056\/NEJMra2216081","volume":"389","author":"ML Durand","year":"2023","unstructured":"Durand ML, Barshak MB, Sobrin L (2023) Eye infections. N Engl J Med 389(25):2363\u20132375. https:\/\/doi.org\/10.1056\/NEJMra2216081","journal-title":"N Engl J Med"},{"key":"544_CR3","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciae104","author":"JM Miller","year":"2024","unstructured":"Miller JM, Binnicker MJ, Campbell S et al (2024) Guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2024 update by the IDSA and ASM. Clin Infect Dis. https:\/\/doi.org\/10.1093\/cid\/ciae104","journal-title":"Clin Infect Dis"},{"issue":"1106","key":"544_CR4","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1136\/postgradmedj-2017-134891","volume":"93","author":"U Krishna","year":"2017","unstructured":"Krishna U, Ajanaku D, Denniston AK, Gkika T (2017) Uveitis: a sight-threatening disease which can impact all systems. Postgrad Med J 93(1106):766\u2013773. https:\/\/doi.org\/10.1136\/postgradmedj-2017-134891","journal-title":"Postgrad Med J"},{"issue":"2","key":"544_CR5","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41435-022-00168-6","volume":"23","author":"XF Huang","year":"2022","unstructured":"Huang XF, Brown MA (2022) Progress in the genetics of uveitis. Genes Immun 23(2):57\u201365. https:\/\/doi.org\/10.1038\/s41435-022-00168-6","journal-title":"Genes Immun"},{"issue":"4\u20135","key":"544_CR6","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.autrev.2014.01.006","volume":"13","author":"C Selmi","year":"2014","unstructured":"Selmi C (2014) Diagnosis and classification of autoimmune uveitis. Autoimmun Rev 13(4\u20135):591\u2013594. https:\/\/doi.org\/10.1016\/j.autrev.2014.01.006","journal-title":"Autoimmun Rev"},{"issue":"2","key":"544_CR7","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ophtha.2017.08.007","volume":"125","author":"DA Jabs","year":"2018","unstructured":"Jabs DA (2018) Immunosuppression for the uveitides. Ophthalmology 125(2):193\u2013202. https:\/\/doi.org\/10.1016\/j.ophtha.2017.08.007","journal-title":"Ophthalmology"},{"key":"544_CR8","doi-asserted-by":"publisher","first-page":"117822182311720","DOI":"10.1177\/11782218231172054","volume":"17","author":"KN Farrelly","year":"2023","unstructured":"Farrelly KN, Wardell JD, Marsden E et al (2023) The impact of recreational cannabis legalization on cannabis use and associated outcomes: a systematic review. Subst Abuse 17:11782218231172054. https:\/\/doi.org\/10.1177\/11782218231172054","journal-title":"Subst Abuse"},{"key":"544_CR9","unstructured":"Substance Abuse and Mental Health Services Administration (2020) Key substance use and mental health indicators in the United States: results from the 2019 national survey on drug use and health"},{"issue":"6","key":"544_CR10","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1111\/bph.12545","volume":"171","author":"JT Toguri","year":"2014","unstructured":"Toguri JT, Lehmann C, Laprairie RB et al (2014) Anti-inflammatory effects of cannabinoid CB2 receptor activation in endotoxin-induced uveitis. Br J Pharmacol 171(6):1448\u20131461. https:\/\/doi.org\/10.1111\/bph.12545","journal-title":"Br J Pharmacol"},{"key":"544_CR11","doi-asserted-by":"publisher","first-page":"304","DOI":"10.3389\/fphar.2016.00304","volume":"7","author":"JT Toguri","year":"2016","unstructured":"Toguri JT, Caldwell M, Kelly ME (2016) Turning down the thermostat: modulating the endocannabinoid system in ocular inflammation and pain. Front Pharmacol 7:304. https:\/\/doi.org\/10.3389\/fphar.2016.00304","journal-title":"Front Pharmacol"},{"key":"544_CR12","doi-asserted-by":"publisher","first-page":"852029","DOI":"10.3389\/fphar.2022.852029","volume":"13","author":"N Aloufi","year":"2022","unstructured":"Aloufi N, Namkung Y, Traboulsi H et al (2022) Standardized cannabis smoke extract induces inflammation in human lung fibroblasts. Front Pharmacol 13:852029. https:\/\/doi.org\/10.3389\/fphar.2022.852029","journal-title":"Front Pharmacol"},{"issue":"12","key":"544_CR13","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1001\/jamapsychiatry.2019.2516","volume":"76","author":"T Da Silva","year":"2019","unstructured":"Da Silva T, Hafizi S, Watts JJ et al (2019) In vivo imaging of translocator protein in long-term cannabis users. JAMA Psychiatry 76(12):1305\u20131313. https:\/\/doi.org\/10.1001\/jamapsychiatry.2019.2516","journal-title":"JAMA Psychiatry"},{"issue":"2","key":"544_CR14","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.survophthal.2020.07.002","volume":"66","author":"MTM Wang","year":"2021","unstructured":"Wang MTM, Danesh-Meyer HV (2021) Cannabinoids and the eye. Surv Ophthalmol 66(2):327\u2013345. https:\/\/doi.org\/10.1016\/j.survophthal.2020.07.002","journal-title":"Surv Ophthalmol"},{"key":"544_CR15","doi-asserted-by":"publisher","first-page":"1500179","DOI":"10.3389\/fmed.2025.1500179","volume":"12","author":"T Charytoniuk","year":"2025","unstructured":"Charytoniuk T, P\u00f3\u0142janowski S, Michalak M et al (2025) The endocannabinoid system and ophthalmic pathologies: a review of molecular mechanisms and its implications for clinical practice. Front Med (Lausanne) 12:1500179. https:\/\/doi.org\/10.3389\/fmed.2025.1500179","journal-title":"Front Med (Lausanne)"},{"issue":"10","key":"544_CR16","doi-asserted-by":"publisher","first-page":"4535","DOI":"10.1167\/iovs.07-1319","volume":"49","author":"M Iribarne","year":"2008","unstructured":"Iribarne M, Torbidoni V, Juli\u00e1n K et al (2008) Cannabinoid receptors in conjunctival epithelium: identification and functional properties. Invest Ophthalmol Vis Sci 49(10):4535\u20134544. https:\/\/doi.org\/10.1167\/iovs.07-1319","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"544_CR17","doi-asserted-by":"publisher","unstructured":"Page RL 2nd, Allen LA, Kloner RA et al (2020) Medical marijuana, recreational cannabis, and cardiovascular health: a scientific statement from the American heart association. Circulation 142(10):e131\u2013e152. https:\/\/doi.org\/10.1161\/CIR.0000000000000883","DOI":"10.1161\/CIR.0000000000000883"},{"issue":"3","key":"544_CR18","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.3390\/ijms24032513","volume":"24","author":"C Pagano","year":"2023","unstructured":"Pagano C, Savarese B, Coppola L et al (2023) Cannabinoids in the modulation of oxidative signaling. Int J Mol Sci 24(3):2513. https:\/\/doi.org\/10.3390\/ijms24032513","journal-title":"Int J Mol Sci"},{"key":"544_CR19","doi-asserted-by":"publisher","first-page":"3529","DOI":"10.2147\/OPTH.S501494","volume":"18","author":"M Bondok","year":"2024","unstructured":"Bondok M, Nguyen AX, Lando L, Wu AY (2024) Adverse ocular impact and emerging therapeutic potential of cannabis and cannabinoids: a narrative review. Clin Ophthalmol 18:3529\u20133556. https:\/\/doi.org\/10.2147\/OPTH.S501494","journal-title":"Clin Ophthalmol"},{"issue":"6","key":"544_CR20","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1001\/jamaophthalmol.2017.1009","volume":"135","author":"DS Borkar","year":"2017","unstructured":"Borkar DS, Homayounfar G, Tham VM et al (2017) Association between thyroid disease and uveitis: results from the Pacific ocular inflammation study. JAMA Ophthalmol 135(6):594\u2013599. https:\/\/doi.org\/10.1001\/jamaophthalmol.2017.1009","journal-title":"JAMA Ophthalmol"},{"issue":"6","key":"544_CR21","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1089\/thy.2016.0598","volume":"27","author":"A Rosenblatt","year":"2017","unstructured":"Rosenblatt A, Zaitoon H, Habot-Wilner Z (2017) Association between non-infectious uveitis and thyroid dysfunction: a case control study. Thyroid 27(6):757\u2013761. https:\/\/doi.org\/10.1089\/thy.2016.0598","journal-title":"Thyroid"}],"container-title":["Journal of Ophthalmic Inflammation and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12348-025-00544-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12348-025-00544-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12348-025-00544-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T15:33:41Z","timestamp":1762875221000},"score":1,"resource":{"primary":{"URL":"https:\/\/joii-journal.springeropen.com\/articles\/10.1186\/s12348-025-00544-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,11]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["544"],"URL":"https:\/\/doi.org\/10.1186\/s12348-025-00544-z","relation":{},"ISSN":["1869-5760"],"issn-type":[{"value":"1869-5760","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,11]]},"assertion":[{"value":"24 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"TriNetX complies with the Health Insurance Portability and Accountability Act (HIPAA), a U.S. federal law ensuring the privacy and security of healthcare data. Additionally, it is certified under the ISO 27001:2013 standard and maintains an Information Security Management System (ISMS) for data protection. Consequently, informed consent was not required for this study. Institutional Review Board (IRB) approval was not required for this study, as it involved analysis of an anonymous database and did not involve any human subject identifiers.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"82"}}